Allspring Global Investments Holdings LLC Reduces Holdings in Spok Holdings, Inc. (NASDAQ:SPOK)

Allspring Global Investments Holdings LLC lessened its holdings in Spok Holdings, Inc. (NASDAQ:SPOK) by 21.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 66,101 shares of the Wireless communications provider’s stock after selling 17,885 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Spok were worth $995,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. nVerses Capital LLC acquired a new position in Spok in the 3rd quarter valued at about $27,000. Gladius Capital Management LP acquired a new position in Spok in the 2nd quarter valued at $112,000. SG Americas Securities LLC purchased a new stake in Spok in the 3rd quarter valued at about $116,000. BNP Paribas Financial Markets grew its holdings in Spok by 82.8% in the first quarter. BNP Paribas Financial Markets now owns 8,577 shares of the Wireless communications provider’s stock valued at $137,000 after purchasing an additional 3,884 shares during the period. Finally, Principal Financial Group Inc. acquired a new stake in shares of Spok during the 1st quarter worth $170,000. 50.81% of the stock is currently owned by institutional investors and hedge funds.

Spok Stock Performance

Shares of NASDAQ:SPOK opened at $15.57 on Friday. The firm has a 50 day simple moving average of $14.96 and a 200 day simple moving average of $15.06. Spok Holdings, Inc. has a 52 week low of $13.24 and a 52 week high of $18.14. The company has a market cap of $315.23 million, a PE ratio of 18.76 and a beta of 0.33.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. StockNews.com upgraded Spok from a “hold” rating to a “buy” rating in a report on Friday, October 25th. B. Riley initiated coverage on shares of Spok in a research note on Thursday, September 26th. They issued a “neutral” rating and a $15.00 price target for the company.

Insider Transactions at Spok

In related news, COO Michael W. Wallace sold 25,000 shares of Spok stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $14.80, for a total transaction of $370,000.00. Following the sale, the chief operating officer now directly owns 49,465 shares of the company’s stock, valued at $732,082. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Spok news, CEO Vincent D. Kelly sold 45,000 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $14.83, for a total value of $667,350.00. Following the completion of the sale, the chief executive officer now owns 201,645 shares of the company’s stock, valued at approximately $2,990,395.35. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Michael W. Wallace sold 25,000 shares of Spok stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $14.80, for a total value of $370,000.00. Following the transaction, the chief operating officer now owns 49,465 shares in the company, valued at approximately $732,082. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.88% of the stock is owned by corporate insiders.

About Spok

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.